Autophagy inducer rapamycin treatment reduces IFN-I-mediated Inflammation and improves anti-HIV-1 T cell response in vivo

By sjmartinez • December 13, 2022

Mu W, Rezek V, Martin H, Carrillo MA, Tomer S, Hamid P, Lizarraga MA, Tibbe TD, Yang OO, Jamieson BD, Kitchen SG, Zhen A. Autophagy inducer rapamycin treatment reduces IFN-I-mediated Inflammation and improves anti-HIV-1 T cell response in vivo. JCI Insight. 2022 Nov 22;7(22):e159136. doi: 10.1172/jci.insight.159136. PMID: 36509289.

Tags: AIDS/HIV, Cellular immune response, Hematology/Oncology, Infectious Diseases, Inflammation, innate immunity, Publications

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer

Saeed A, Tabernero J, Parikh A, den Eynde MV, Karthaus M, Gerlinger M, Wang Z, Wang G, Smith R, Hecht JR. STELLAR-303: randomized phase III[...]

A Rare Case of Life-Threatening Hemorrhage

Soni M, Penn J. A Rare Case of Life-Threatening Hemorrhage. Cureus. 2024 Jun 21;16(6):e62878. doi: 10.7759/cureus.62878. PMID: 39040757; PMCID: PMC11261237.

Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report

Cheng JJ, Shen J, Suresh Y, Akopyan NA, Kapoor NS. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: Case report.[...]